Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−8.2996 USD
−8.77 M USD
4.35 K USD
2.63 M
About HeartSciences Inc.
Sector
Industry
CEO
Andrew Christopher Simpson
Website
Headquarters
Southlake
Founded
2007
ISIN
US42254E1120
FIGI
BBG0185L9036
HeartSciences, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. The firm offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded on August 16, 2007 and is headquartered in Southlake, TX.
Displays a symbol's price movements over previous years to identify recurring trends.